charles khouri
机构: Pharmacologist, Grenoble Alpes University Hospital
每年引用次数
引用次数
引用: 1,563
H-指数: 23
I10-指数 : 38
出版物: 156
Effect of intensity of home noninvasive ventilation in individuals with neuromuscular and chest wall disorders: a systematic review and meta-analysis of individual participant data
Mathieu Delorme , Antoine Leotard , Marius Lebret , Claire Lefeuvre
Archivos de bronconeumologia 59 ( 8) 488 -496
3
2023
Identifying new drugs associated with pulmonary arterial hypertension: a WHO pharmacovigilance database disproportionality analysis
Alex Hlavaty , Matthieu Roustit , David Montani , Marie‐Camille Chaumais
British Journal of Clinical Pharmacology 88 ( 12) 5227 -5237
9
2022
Characteristics and outcomes of patients developing pulmonary hypertension associated with proteasome inhibitors
Julien Grynblat , Charles Khouri , Alex Hlavaty , Xavier Jais
European Respiratory Journal
1
2024
Pulmonary hypertension associated with diazoxide: the SUR1 paradox
David Montani , Fabrice Antigny , Etienne-Marie Jutant , Marie-Camille Chaumais
ERJ Open Research 9 ( 6)
1
2023
Characteristics and outcomes of gemcitabine-associated pulmonary hypertension
Pierre Mouillot , Nicolas Favrolt , Charles Khouri , Aurélie Grandvuillemin
ERJ Open Research 10 ( 3)
2024
Development and validation of a code-based algorithm using in-hospital medical records to identify patients with pulmonary arterial hypertension in the French Healthcare Database
Clément Jambon-Barbara , Alex Hlavaty , Claire Bernardeau , Hélène Bouvaist
ERJ Open Research
2024
Antipsychotics and drug-induced liver injury: toward minimum requirements in reporting pharmacovigilance studies
Emanuel Raschi , Georgios Schoretsanitis , Chiara Gastaldon , Charles Khouri
Journal of Clinical Psychopharmacology 43 ( 1) 81 -83
3
2023
Meta-analyzing results from disproportionality analysis of individual case safety reports: a note of caution
Michele Fusaroli , Charles Khouri , Elisabetta Poluzzi , Fabrizio De Ponti
Journal of Clinical Psychopharmacology 44 ( 4) 443 -444
1
2024
Peer Review in Pharmacovigilance: Lens on Disproportionality Analysis
Emanuel Raschi , Francesco Salvo , Andrew Bate , Fabrizio De Ponti
Drug Safety 1 -5
2024
High prevalence of spin was found in pharmacovigilance studies using disproportionality analyses to detect safety signals: a meta-epidemiological study
Amelle Mouffak , Marion Lepelley , Bruno Revol , Claire Bernardeau
Journal of Clinical Epidemiology 138 73 -79
25
2021
Pharmacology of Raynaud's phenomenon
Matthieu Roustit , Charles Khouri , Sophie Blaise , Celine Villier
Therapie 69 ( 2) 115 -128
9
2014
Adverse event reporting and Bell's palsy risk after COVID-19 vaccination
Charles Khouri , Matthieu Roustit , Jean-Luc Cracowski
The Lancet Infectious Diseases 21 ( 11) 1490 -1491
7
2021
Drug-induced skin ulcers: A disproportionality analysis from the WHO pharmacovigilance database
Dorothée Duron , Sophie Blaise , Jean-Luc Cracowski , Matthieu Roustit
Journal of the American Academy of Dermatology 85 ( 1) 229 -232
7
2021
Investigating the link between drug consumption and adverse events reporting in France
Pauline Orhon , Marion Robert , Thomas Morand , Jean‐Luc Cracowski
Fundamental & Clinical Pharmacology 37 ( 4) 879 -882
4
2023
Placebo response in Raynaud's Phenomenon clinical trials: the prominent role of regression towards the mean: placebo response in Raynaud's Phenomenon
Matthieu Roustit , Ariane Jullien , Clément Jambon-Barbara , Hugo Goudon
Seminars in Arthritis and Rheumatism 57 152087 -152087
4
2022
Douleurs musculaires et statines, effet pharmaco ou effet nocebo?
Charles Khouri , Marion Lepelley , Michel Mallaret , Matthieu Roustit
Therapies 73 ( 4) 359 -361
3
2018
Mouse models of diabetes-related ulcers: a systematic review and network meta-analysis
Axel Couturier , Clément Calissi , Jean-Luc Cracowski , Dominique Sigaudo-Roussel
EBioMedicine 98
1
2023
Assessment of Reported Adverse Events After Interchanging Between TNF-α Inhibitor Biosimilars in the WHO Pharmacovigilance Database
Orhon Pauline , Marion Robert , Claire Bernardeau , Alex Hlavaty
BioDrugs 37 ( 5) 699 -707
1
2023
Risk of skin ulcer and use of COX-2 inhibitors: A national population-based nested case control study
J Perez , Matthieu Roustit , Julien Bezin , Sophie Blaise
European Journal of Clinical Pharmacology 78 ( SUPPL 1) S25 -S25
1
2022
Triptans and SCAD: an analysis from the WHO pharmacovigilance database
Justine Perez , Marion Lepelley , Bruno Revol , Matthieu Roustit
Journal of the American College of Cardiology 78 ( 21) 2129 -2130
1
2021